dc.contributor.author | Moore, KM | en_US |
dc.contributor.author | Thomas, GJ | en_US |
dc.contributor.author | Duffy, SW | en_US |
dc.contributor.author | Warwick, J | en_US |
dc.contributor.author | Gabe, R | en_US |
dc.contributor.author | Chou, P | en_US |
dc.contributor.author | Ellis, IO | en_US |
dc.contributor.author | Green, AR | en_US |
dc.contributor.author | Haider, S | en_US |
dc.contributor.author | Brouilette, K | en_US |
dc.contributor.author | Saha, A | en_US |
dc.contributor.author | Vallath, S | en_US |
dc.contributor.author | Bowen, R | en_US |
dc.contributor.author | Chelala, C | en_US |
dc.contributor.author | Eccles, D | en_US |
dc.contributor.author | Tapper, WJ | en_US |
dc.contributor.author | Thompson, AM | en_US |
dc.contributor.author | Quinlan, P | en_US |
dc.contributor.author | Jordan, L | en_US |
dc.contributor.author | Gillett, C | en_US |
dc.contributor.author | Brentnall, A | en_US |
dc.contributor.author | Violette, S | en_US |
dc.contributor.author | Weinreb, PH | en_US |
dc.contributor.author | Kendrew, J | en_US |
dc.contributor.author | Barry, ST | en_US |
dc.contributor.author | Hart, IR | en_US |
dc.contributor.author | Jones, JL | en_US |
dc.contributor.author | Marshall, JF | en_US |
dc.date.accessioned | 2015-09-22T14:21:02Z | |
dc.date.issued | 2014-08 | en_US |
dc.identifier.issn | 0027-8874 | en_US |
dc.identifier.other | 10.1093/jnci/dju169 | |
dc.identifier.other | ARTN dju169 | en_US |
dc.identifier.other | ARTN dju169 | en_US |
dc.identifier.other | ARTN dju169 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/8829 | |
dc.description | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. | en_US |
dc.description.sponsorship | This research was supported by grants from Breast Cancer Campaign (BCC 2008 May PR32) and the Medical Research Council (MRC G0800825). | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | en_US |
dc.title | Therapeutic Targeting of Integrin alpha v beta 6 in Breast Cancer | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/jnci/dju169 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341637800012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 8 | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 106 | en_US |